{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T01:29:58Z","timestamp":1784165398852,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100022416","name":"Center for Drug Evaluation and Research","doi-asserted-by":"publisher","award":["Center for Drug Evaluation and Research"],"award-info":[{"award-number":["Center for Drug Evaluation and Research"]}],"id":[{"id":"10.13039\/100022416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Canc Educ"],"DOI":"10.1007\/s13187-025-02774-0","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T12:23:13Z","timestamp":1763209393000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cancer Survivors\u2019 and Caregivers\u2019 Understanding of FDA Accelerated Approval Disclosures"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7621-7554","authenticated-orcid":false,"given":"Helen W.","family":"Sullivan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amie C.","family":"O\u2019Donoghue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,15]]},"reference":[{"key":"2774_CR1","unstructured":"Federal, Food Drug, and Cosmetic Act, Sect.\u00a0506(c)"},{"key":"2774_CR2","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1001\/jamaoncol.2017.5618","volume":"4","author":"JA Beaver","year":"2018","unstructured":"Beaver JA, Howie LJ, Pelosof L, Kim T, Liu J, Goldberg KB, Sridhara R, Blumenthal GM, Farrell AT, Keegan P, Pazdur R (2018) A 25-year experience of US food and drug administration accelerated approval of malignant hematology and oncology drugs and biologics: a review. JAMA Oncol 4:849\u2013856","journal-title":"JAMA Oncol"},{"key":"2774_CR3","unstructured":"21 CFR Sect.\u00a0201.57(c)(2)(i)(B)"},{"key":"2774_CR4","unstructured":"US Food and Drug Administration (2019) Accessed February 26, 2025. https:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM390058.pdf"},{"key":"2774_CR5","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/pds.4664","volume":"27","author":"HW Sullivan","year":"2018","unstructured":"Sullivan HW, O\u2019Donoghue AC, David KT, Patel NJ (2018) Disclosing accelerated approval on direct-to\u2010consumer prescription drug websites. Pharmacoepidemiol Drug Saf 27:1277\u20131280","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"S7","key":"2774_CR6","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1002\/cncr.23653","volume":"113","author":"AL Back","year":"2008","unstructured":"Back AL, Anderson WG, Bunch L, Marr LA, Wallace JA, Yang HB, Arnold RM (2008) Communication about cancer near the end of life. Cancer 113(S7):1897\u20131910","journal-title":"Cancer"},{"key":"2774_CR7","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/j.pec.2020.03.018","volume":"103","author":"V Boudewyns","year":"2020","unstructured":"Boudewyns V, Southwell BG, DeFrank JT, Ferriola-Bruckenstein K, Halpern MT, O\u2019Donoghue AC, Sullivan HW (2020) Patients\u2019 understanding of oncology clinical endpoints: a literature review. Patient Educ Couns 103:1724\u20131735","journal-title":"Patient Educ Couns"},{"key":"2774_CR8","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1111\/hex.13822","volume":"26","author":"M Edwards","year":"2023","unstructured":"Edwards M, Holland-Hart D, Mann M, Seddon K, Buckle P, Longo M, Byrne A, Nelson A (2023) Understanding how shared decision\u2010making approaches and patient aids influence patients with advanced cancer when deciding on palliative treatments and care: a realist review. Health Expect 26:2109\u20132126","journal-title":"Health Expect"},{"issue":"21","key":"2774_CR9","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1200\/JCO.2005.03.6236","volume":"24","author":"R Matsuyama","year":"2006","unstructured":"Matsuyama R, Reddy S, Smith TJ (2006) Why do patients choose chemotherapy near the end of life? A review of the perspective of those facing death from cancer. J Clin Oncol 24(21):3490\u20133496","journal-title":"J Clin Oncol"},{"issue":"2","key":"2774_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s13187-016-1107-1","volume":"33","author":"HW Sullivan","year":"2018","unstructured":"Sullivan HW, Aikin KJ, Squiers LB (2018) Quantitative information on oncology prescription drug websites. J Cancer Educ 33(2):371\u2013374","journal-title":"J Cancer Educ"},{"key":"2774_CR11","volume-title":"Oncology marketing goes prime time: pharma brands move to DTC advertising to capture market share","author":"K McCaffrey","year":"2017","unstructured":"McCaffrey K (2017) Oncology marketing goes prime time: pharma brands move to DTC advertising to capture market share. MM&M\/Haymarket Media, Inc., New York, NY"},{"key":"2774_CR12","doi-asserted-by":"crossref","unstructured":"Davis C, Wagner AK, Salcher-Konrad M, Scowcroft H, Mintzes B, Pokorny AM, Lew J, Naci H (2023) Communication of anticancer drug benefits and related uncertainties to patients and clinicians: document analysis of regulated information on prescription drugs in Europe. BMJ. 380:e073711","DOI":"10.1136\/bmj-2022-073711"},{"issue":"16","key":"2774_CR13","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1001\/archinternmed.2011.396","volume":"171","author":"LM Schwartz","year":"2011","unstructured":"Schwartz LM, Woloshin S (2011) Communicating uncertainties about prescription drugs to the public: a national randomized trial. Arch Intern Med 171(16):1463\u20131468","journal-title":"Arch Intern Med"},{"issue":"57","key":"2774_CR14","first-page":"16743","volume":"87","author":"US Food and Drug Administration","year":"2022","unstructured":"US Food and Drug Administration (2022) Accelerated approval disclosures on direct-to-consumer prescription drug websites. Fed Register Notice 87(57):16743\u201316748","journal-title":"Fed Register Notice"},{"key":"2774_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-7-21","volume":"7","author":"NS Morris","year":"2006","unstructured":"Morris NS, MacLean CD, Chew LD, Littenberg B (2006) The single item literacy screener: evaluation of a brief instrument to identify limited reading ability. BMC Fam Pract 7:21","journal-title":"BMC Fam Pract"},{"key":"2774_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad064","volume":"28","author":"HW Sullivan","year":"2023","unstructured":"Sullivan HW, O\u2019Donoghue AC, Boudewyns V, Paquin RS, Ferriola-Bruckenstein K (2023) Patient understanding of oncology clinical trial endpoints in direct-to-consumer television advertising. Oncologist 28:e542\u2013e553","journal-title":"Oncologist"}],"container-title":["Journal of Cancer Education"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13187-025-02774-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13187-025-02774-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13187-025-02774-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T12:23:14Z","timestamp":1763209394000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13187-025-02774-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":16,"alternative-id":["2774"],"URL":"https:\/\/doi.org\/10.1007\/s13187-025-02774-0","relation":{},"ISSN":["0885-8195","1543-0154"],"issn-type":[{"value":"0885-8195","type":"print"},{"value":"1543-0154","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,15]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study received an exemption from RTI International\u2019s institutional review board. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict interest"}},{"value":"This article reflects the views of the authors and should not be construed to represent FDA\u2019s views or policies.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Note"}}]}}